
MedApp S.A. is a technology company focused on digital medicine and advanced diagnostic imaging solutions. Their innovative products aim to revolutionize patient treatment and life-saving procedures. The company develops technologies that support image diagnostics and next-generation digital medicine, with a focus on AI, 3D imaging, and Big Data analysis. MedApp's solutions include CarnaLife System for remote patient monitoring, CarnaLife Holo for 3D medical imaging visualization, HoloComm for remote 3D product demonstrations, and Cyfrowa Przychodnia for integrated consultation, diagnosis, and health monitoring. The company emphasizes its strong R&D capabilities, international collaborations with tech and medical leaders like Microsoft and GE, and a scientific advisory board of recognized medical experts. MedApp has achieved an FDA certification for its CarnaLife Holo software and has notable case studies showcasing its technology in use at leading medical centers.

MedApp S.A. is a technology company focused on digital medicine and advanced diagnostic imaging solutions. Their innovative products aim to revolutionize patient treatment and life-saving procedures. The company develops technologies that support image diagnostics and next-generation digital medicine, with a focus on AI, 3D imaging, and Big Data analysis. MedApp's solutions include CarnaLife System for remote patient monitoring, CarnaLife Holo for 3D medical imaging visualization, HoloComm for remote 3D product demonstrations, and Cyfrowa Przychodnia for integrated consultation, diagnosis, and health monitoring. The company emphasizes its strong R&D capabilities, international collaborations with tech and medical leaders like Microsoft and GE, and a scientific advisory board of recognized medical experts. MedApp has achieved an FDA certification for its CarnaLife Holo software and has notable case studies showcasing its technology in use at leading medical centers.
Headquarters: Kraków, Poland
Core products: CarnaLife Holo (3D/mixed-reality visualization), CarnaLife System (digital clinic / remote monitoring)
Focus areas: Digital medicine, medical imaging, AI, 3D visualization, remote patient monitoring
Regulatory milestone: FDA certification for CarnaLife Holo
Investor / ownership update: Doktor Guzik Family Foundation acquired 51.81% stake (April 2024)
Improving diagnostic imaging visualization, enabling remote patient monitoring and digital clinical workflows.
2011
Medtech / Digital Health
EUR 7,881,329.46 (total project value)
MedApp listed as one of 17 partners in the I3 project 'We Are Health Champions' (consortium grant award).
nearly EUR 6,000,000
Distribution agreement in Poland described as worth nearly EUR 6 million.
Doktor Guzik Family Foundation acquired a 51.81% controlling stake in early April 2024.
“Doktor Guzik Family Foundation holds a 51.81% controlling stake (April 2024)”